Samantha Lynn Bailey

Graduate Student

Samantha Bailey is a PhD Candidate in the Clinical Pharmaceutical Scientist track under the mentorship of Dr. Philip Empey. Her research interests include large-scale population research, pharmacogenomics, depressive disorders, and education. Samantha earned her Doctor of Pharmacy degree with an Area of Concentration in Research from the University of Pittsburgh School of Pharmacy in 2020 and is a licensed pharmacist in Pennsylvania. That same year, she was honored as an inaugural Scholar of the National Human Genome Research Institute’s (NHGRI) Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG). In addition, Samantha completed a master’s level certificate in Clinical and Translational Research at the University of Pittsburgh School of medicine in 2021. She refined her research skills as an ORISE Fellow in the Department of Translational and Precision Medicine (DTPM) at the U.S. Food and Drug Administration in 2024, where she evaluated intrinsic and extrinsic factors in drug labeling.

Graduate Track Affiliation(s)
Clinical Pharmaceutical Sciences
Graduate Program Affiliation(s)
PhD in Pharmaceutical Sciences: Clinical Pharmaceutical Scientist Program
Honors / Awards
Randy and Renee Juhl Graduate Scholar Award (2023, 2024)
Recent Publications

Bailey SL, Stern S, Dahmane E, Ramamoorthy A, Pacanowski M, Schuck R. The Evaluation of Interactions Between Multiple Intrinsic and Extrinsic Factors Reported in Labeling for FDA-Approved Drugs. J Clin Pharmacol. Published online June 26, 2025. doi:10.1002/jcph.70064 

Bailey SL, Messersmith D, Empey PE. Pharmacogenomics education among professional societies: assessing practices and future needs. Pharmacogenomics. 2025;26(3-4):81-87. doi:10.1080/14622416.2025.2502316 

Rogers H, Adeniyi O, Ramamoorthy A, Bailey S, Pacanowski M. Clinical Pharmacology Studies Supporting Oligonucleotide Therapy Development: An Assessment of Therapies Approved and in Development Between 2012 and 2018. Clin Transl Sci. 2021;14(2):468-475. doi:10.1111/cts.12945. (Cited in Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics. FDA. 2022)

Presentations
Landscape analysis of pharmacogenomic education within ISCC-PEG partner organizations. Class of 2020-2022 Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG) Scholar Presentations, Virtual, October 2022.

Disseminating pharmacogenomic education: understanding the needs of ISCC-PEG partner organizations. Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG) 11th Annual Meeting, Virtual, February 2022.
Advisor
Philip Empey